Healthcare ETF Defies Market Slump as Key Holding Surges 15% on Major AI Drug Discovery Alliance

Stock News

昨天

ChinaAMC Hang Seng Biotech ETF (03069) climbed more than 2% against the broader market's downturn, trading 1.96% higher at HK$15.63 as of press time, with turnover reaching HK$27.30 million.

GenScript Biotech (01548), one of the top ten holdings in the ChinaAMC Hang Seng Biotech ETF, skyrocketed 15% today following its announcement of a collaboration with Eli Lilly's AI/machine learning drug discovery platform, Lilly TuneLab. Additionally, Novo Nordisk and Anthropic have signed a cooperation agreement, together fueling gains across the AI-driven pharmaceutical supply chain.

Where to begin with this momentum? Public filings show the ChinaAMC Hang Seng Biotech ETF tracks the Hang Seng Biotechnology Index, with constituent stocks including GenScript Biotech, Innovent Biologics, and BeiGene—a roster of leading China-based biotech firms with global competitiveness. The ETF was officially included in the Stock Connect program on July 22, 2024, making it one of the accessible Hong Kong-listed ETFs for mainland investors seeking exposure to innovative drugs and biotech through the channel.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1178899864"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1178899864\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1178899864?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-17 10:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178899864","market":"fut","top_or_hot":-1,"title":"Healthcare ETF Defies Market Slump as Key Holding Surges 15% on Major AI Drug Discovery Alliance","media":"Stock News","content":"<p><b>ChinaAMC Hang Seng Biotech ETF (03069)</b> climbed more than 2% against the broader market's downturn, trading 1.96% higher at HK$15.63 as of press time, with turnover reaching HK$27.30 million.<br><br><b>GenScript Biotech (01548)</b>, one of the top ten holdings in the ChinaAMC Hang Seng Biotech ETF, skyrocketed 15% today following its announcement of a collaboration with <b>Eli Lilly's</b> AI/machine learning drug discovery platform, Lilly TuneLab. Additionally, <b>Novo Nordisk</b> and <b>Anthropic</b> have signed a cooperation agreement, together fueling gains across the AI-driven pharmaceutical supply chain.<br><br>Where to begin with this momentum? Public filings show the ChinaAMC Hang Seng Biotech ETF tracks the Hang Seng Biotechnology Index, with constituent stocks including <b>GenScript Biotech</b>, <b>Innovent Biologics</b>, and <b>BeiGene</b>—a roster of leading China-based biotech firms with global competitiveness. The ETF was officially included in the Stock Connect program on July 22, 2024, making it one of the accessible Hong Kong-listed ETFs for mainland investors seeking exposure to innovative drugs and biotech through the channel.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Healthcare ETF Defies Market Slump as Key Holding Surges 15% on Major AI Drug Discovery Alliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealthcare ETF Defies Market Slump as Key Holding Surges 15% on Major AI Drug Discovery Alliance\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-09-17 10:20</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><b>ChinaAMC Hang Seng Biotech ETF (03069)</b> climbed more than 2% against the broader market's downturn, trading 1.96% higher at HK$15.63 as of press time, with turnover reaching HK$27.30 million.<br><br><b>GenScript Biotech (01548)</b>, one of the top ten holdings in the ChinaAMC Hang Seng Biotech ETF, skyrocketed 15% today following its announcement of a collaboration with <b>Eli Lilly's</b> AI/machine learning drug discovery platform, Lilly TuneLab. Additionally, <b>Novo Nordisk</b> and <b>Anthropic</b> have signed a cooperation agreement, together fueling gains across the AI-driven pharmaceutical supply chain.<br><br>Where to begin with this momentum? Public filings show the ChinaAMC Hang Seng Biotech ETF tracks the Hang Seng Biotechnology Index, with constituent stocks including <b>GenScript Biotech</b>, <b>Innovent Biologics</b>, and <b>BeiGene</b>—a roster of leading China-based biotech firms with global competitiveness. The ETF was officially included in the Stock Connect program on July 22, 2024, making it one of the accessible Hong Kong-listed ETFs for mainland investors seeking exposure to innovative drugs and biotech through the channel.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01477","symbol_name":"歐康維視生物-B","start_time":0,"source_url":"","article_id":"1178899864","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178899864","pubTimestamp":1789611607,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"ChinaAMC Hang Seng Biotech ETF (03069) climbed more than 2% against the broader market's downturn, trading 1.96% higher at HK$15.63 as of press time, with turnover reaching HK$27.30 million.GenScript...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01477":"欧康维视生物-B","BK1191":"制药","ARTY":"ISHARES FUTURE AI & TECH ETF","AIPO":"Defiance AI and Power Infrastructure ETF","FDN":"First Trust Dow Jones Internet I","03069":"华夏恒生生科","BK4550":"红杉资本持仓","BK4588":"碎股","AGIX":"通用人工智能 ETF-AGIX","BK4585":"ETF&股票定投概念","BK1574":"生物医药B类股","VTHR":"Vanguard Russell 3000 ETF","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","QTOC":"Innovator Growth Accelerated Plus ETF - October"},"translate_title":"主要人工智能药物发现联盟的关键持股激增 15%，医疗保健 ETF 克服市场低迷","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CHAT":1,"QTOC":1,"FDN":1,"AGIX":1,"01477":1,"ARTY":1,"03069":1,"AIPO":1,"VTHR":1},"content_text":"ChinaAMC Hang Seng Biotech ETF (03069) climbed more than 2% against the broader market's downturn, trading 1.96% higher at HK$15.63 as of press time, with turnover reaching HK$27.30 million.GenScript Biotech (01548), one of the top ten holdings in the ChinaAMC Hang Seng Biotech ETF, skyrocketed 15% today following its announcement of a collaboration with Eli Lilly's AI/machine learning drug discovery platform, Lilly TuneLab. Additionally, Novo Nordisk and Anthropic have signed a cooperation agreement, together fueling gains across the AI-driven pharmaceutical supply chain.Where to begin with this momentum? Public filings show the ChinaAMC Hang Seng Biotech ETF tracks the Hang Seng Biotechnology Index, with constituent stocks including GenScript Biotech, Innovent Biologics, and BeiGene—a roster of leading China-based biotech firms with global competitiveness. The ETF was officially included in the Stock Connect program on July 22, 2024, making it one of the accessible Hong Kong-listed ETFs for mainland investors seeking exposure to innovative drugs and biotech through the channel.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}